Kinetics and seroprevalence of SARS-CoV-2 antibodies: a comparison of 3 different assays

QR Code

Kinetics and seroprevalence of SARS-CoV-2 antibodies: a comparison of 3 different assays

Abstract Comparing seroprevalence and antibody kinetics in three different commercially available assays for SARS-CoV-2. Serostatus of COVID-19 patients was analyzed 5 months and 10 months after their infection, using three different assays: Diasorin LIAISON, Euroimmun, Abbott Diagnostics ARCHITECT....

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Elisabeth Kahre, Lukas Galow, Manja Unrath, Luise Haag, Judith Blankenburg, Alexander H. Dalpke, Christian Lück, Reinhard Berner, Jakob P. Armann
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2021
Sujets:	Medicine R Science Q
Accès en ligne:	https://doaj.org/article/3ad06cb755d9481f99002db848a9c614
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Novel Assay to Measure Seroprevalence of Zika Virus in the Philippines
par: Cameron Adams, et autres
Publié: (2021)

Antibody Responses to SARS-CoV-2 Infection—Comparative Determination of Seroprevalence in Two High-Throughput Assays versus a Sensitive Spike Protein ELISA
par: Dinesh Mohanraj, et autres
Publié: (2021)

Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays
par: Christos Fotis, et autres
Publié: (2021)

SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
par: Kene Nwosu, et autres
Publié: (2021)

Estimated seroprevalence of SARS-CoV-2 antibodies among adults in Orange County, California
par: Tim A. Bruckner, et autres
Publié: (2021)

Seroprevalence of Antibodies to SARS-CoV-2 in Guangdong Province, China between March to June 2020
par: Cheng Xiao, et autres
Publié: (2021)

Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study
par: Anton Barchuk, et autres
Publié: (2021)

Diagnostic value of islet autoantibody assays practised in Russia. 1. Classic immunofluorescence islet cell antibody assay, immunoradiometric glutamic acid decarboxylase antibody assay, and ELISA tyrosine phosphatase antibody and insulin antibody assays
par: Alexei V. Timofeev, et autres
Publié: (2016)

Seroprevalence Of IgG Antibodies Against Borrelia burgdorferi In Dogs In Belgrade Area, Serbia
par: Sonja OBRENOVIĆ, et autres
Publié: (2015)

Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
par: N. Ahmad Aziz, et autres
Publié: (2021)

Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
par: Cruz S. Sebastião, et autres
Publié: (2021)

Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain
par: Marianna Karachaliou, et autres
Publié: (2021)

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital
par: Alberto L. Garcia-Basteiro, et autres
Publié: (2020)

Seroprevalence of antibodies to SARS-CoV-2 and predictors of seropositivity among employees of a teaching hospital in New Delhi, India
par: Pragya Sharma, et autres
Publié: (2021)

Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown
par: Marie-Kathrin Breyer, et autres
Publié: (2021)

Seroprevalence of antibodies against Borrelia burgdorferi sensu lato in healthy blood donors in Romania: an update
par: Zsuzsa Kalmár, et autres
Publié: (2021)

SEROPREVALANCE OF CHLAMYDIA TRACHOMATIS ANTIBODIES IN FEMALES OF REPRODUCTIVE AGE VISITING HOLY FAMILY HOSPITAL, RAWALPINDI
par: Saima Ali Khan, et autres
Publié: (2019)

Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses
par: Natalia Ortega, et autres
Publié: (2021)

Seroprevalence of SARS-CoV-2 antibodies in the general population of Oman: results from four successive nationwide sero-epidemiological surveys
par: Seif Salem Al-Abri, et autres
Publié: (2021)

Seroprevalence of Toxoplasma gondii IgG antibody in HIV-infected patients at the Lagos University Teaching Hospital
par: Osunkalu VO, et autres
Publié: (2011)

Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts
par: Yachana Kataria, et autres
Publié: (2021)

Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome
par: Kristyna Sloupenska, et autres
Publié: (2021)

Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020
par: Mariya Amin Qurieshi, et autres
Publié: (2021)

Determining seropositivity-A review of approaches to define population seroprevalence when using multiplex bead assays to assess burden of tropical diseases.
par: YuYen Chan, et autres
Publié: (2021)

A rebinding-assay for measuring extreme kinetics using label-free biosensors
par: John G. Quinn
Publié: (2021)

Seroprevalences of specific antibodies against avian pathogens in free-ranging ring-necked pheasants (Phasianus colchicus) in Northwestern Germany.
par: Friederike Gethöffer, et autres
Publié: (2021)

A seroprevalence study of Covid 19 antibody after 1st wave of the pandemic in South Andaman district, India
par: Deepak Kumar, et autres
Publié: (2021)

Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features
par: Yannic C. Bartsch, et autres
Publié: (2021)

A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies
par: Patthara Kongsuphol, et autres
Publié: (2021)

High-throughput quantitation of SARS-CoV-2 antibodies in a single-dilution homogeneous assay
par: Markus H. Kainulainen, et autres
Publié: (2021)

Clinical Evaluation of Siemens SARS-CoV-2 Total Antibody assay and IgG assay using the Dimension EXL 200 in the Tokyo Metropolitan area
par: Gene Igawa, et autres
Publié: (2021)

Seroprevalence of Severe Acute Respiratory Syndrome-Coronavirus-2 Immunoglobulin M and Immunoglobulin G Antibodies among the Population of Koya University
par: Safia S. I. Blbas, et autres
Publié: (2021)

Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines
par: Youchun Wang
Publié: (2021)

Seroprevalence of Cat Leptospirosis in Belgrade (Serbia)
par: Sonja Obrenović, et autres
Publié: (2014)

A homogeneous split-luciferase assay for rapid and sensitive detection of anti-SARS CoV-2 antibodies
par: Zhong Yao, et autres
Publié: (2021)

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
par: Ann-Sofie Rudberg, et autres
Publié: (2020)

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
par: Dianna L. Ng, et autres
Publié: (2020)

High seroprevalence of SARS-CoV-2 in elderly care employees in Sweden
par: Johanna F. Lindahl, et autres
Publié: (2020)

Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo.
par: Anna Bratcher, et autres
Publié: (2021)

Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles
par: Huang KW, et autres
Publié: (2012)